← Eichor
Condition: Nephritis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nephritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Phase 1 · 18 location(s) · Regeneron Pharmaceuticals · NCT06975787US Zamto-cel Autoimmune Diseases
Phase 1 · 1 location(s) · Miltenyi Biomedicine GmbH · NCT06708845A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Phase 1 · 14 location(s) · CRISPR Therapeutics · NCT06925542Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT07585981Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Phase 3 · 9 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07390123A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Phase 3 · 31 location(s) · Cerium Pharmaceuticals, Inc. · NCT05696613Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Phase 3 · 1 location(s) · Air Force Military Medical University, China · NCT05510323Lupus Landmark Study: A Prospective Registry and Biorepository
Phase N/A · 25 location(s) · Lupus Research Alliance · NCT05934149RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic
Phase 1/Phase 2 · 23 location(s) · Cabaletta Bio · NCT06121297Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
Phase N/A · 5 location(s) · University of Michigan · NCT01016613An Outcome Analysis of Primary Membranous Nephropathy
Phase N/A · 2 location(s) · Mario Negri Institute for Pharmacological Research · NCT06242327Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07010250A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · 101 location(s) · Novartis Pharmaceuticals · NCT06581198A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome
Phase 2 · 60 location(s) · Bayer · NCT07211685A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite I
Phase 2 · 96 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07015983Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
Phase N/A · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT05443516PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Phase 4 · 15 location(s) · Aurinia Pharmaceuticals Inc. · NCT07611214Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
Phase 4 · 1 location(s) · Institutul Clinic Fundeni · NCT05207358Biomarker Development for Autoimmune Disorders Involving the Kidneys
Phase N/A · 1 location(s) · Oslo University Hospital · NCT07666711NEPTUNE Match Study
NA · 16 location(s) · University of Michigan · NCT04571658A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Phase 1/Phase 2 · 19 location(s) · Nkarta, Inc. · NCT06557265A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07104721Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells
Phase 2 · 1 location(s) · Red de Terapia Celular · NCT03673748Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
NA · 1 location(s) · Botkin Hospital · NCT07056595ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
Phase N/A · 1 location(s) · Christoph Aufricht · NCT06162546A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT06952426Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
Phase 2 · 12 location(s) · Autolus Limited · NCT07053800Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Phase 1/Phase 2 · 1 location(s) · Beijing GoBroad Hospital · NCT06947473A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Phase 3 · 251 location(s) · Biogen · NCT06935357A Study of SHR-2173 in Participants With Primary IgA Nephropathy
Phase 2 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07354932
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.